2023 ´ëÇÑ»ý½Ä¸é¿ªÇÐȸ Ãß°èÇмú´ëȸ : 2023-10-29
±³À°ÀÏÀÚ : 2023-10-29
±³À°Àå¼Ò : ÀÏ¿ø¿ª, »ï¼º»ý¸íºôµù 9F,È÷Æ÷Å©¶óÅ×½ºÈ¦
±³À°ÁÖÁ¦ : 2023 ´ëÇÑ»ý½Ä¸é¿ªÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ»ý½ÄÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý½Ä¸é¿ªÇÐȸ
´ã´çÀÚ : À̽¾Ö
¿¬¶ôó : 010-2639-5763
À̸ÞÀÏ : office@the-ksri.org
±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀÎ : 120¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:10~10:40 Development and function of innate T cells ÀÌÀ¯Á¤(¼¿ï´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:40~11:10 Role of trained immunity in obesity-associated diseases Á¶°è¿ø(¼øõÇâ´ë)
Åä·Ð 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:10~11:20 Discussion ()
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:20~11:55 Exploration of hidden factor X behind placental dysfunction in preeclampsia-insight into novel therapy Takeshi Nagamatsu(International University of Health and Welfare, Japan)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:55~12:30 The effects of progesterone on immunity and implantation M Rafet Gazvani(Liverpool Women)
½Ä»ç 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:30~13:20 ½Ä»ç ()
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:20~13:50 Obesity-induced vaginal microbiota-¥ã¥ä T cell crosstalk protects female reproductive tract from viral infection ÀÌÈï±Ô(KAIST)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:50~14:20 Immune equilibrium in recurrent pregnancy loss ¹é±¤Çö(Â÷ÀÇ°úÇдë)
Åä·Ð 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:20~14:30 Discussion ()
ÈÞ½Ä 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:30~14:40 Coffee Break ()
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:40~15:00 Critical review for Updated guidelines: RPL & RIF ¹ÚÀ±Á¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:00~15:20 Endometrial receptivity & microbiome: EMMA test is promising? ÇѾֶó(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:20~15:40 Exploring potential clinical applications of exosomes in reproductive medicine À±¹Ì¼·(°¡ÃµÀÇ´ë)
Åä·Ð 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:40~15:55 Discussion ()
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:55~16:15 Managements of pregnant women with antiphospholipid syndrome ¼º¿øÁØ(°æºÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:15~16:35 Application of tissue engineering and regeneratvie medicine in prelabor rupture of membranes Á¤¿µ¹Ì(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:35~16:55 Immune-tolerance regulation in feto-maternal interface ¾ç½Â¿ì(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 10¿ù 29ÀÏ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:55~17:10 Discussion ()